SPN-830 Apomorphine Infusion Pump Reduces ‘Off’ Time in Parkinson’s Patients
The open-label INFUS-ON study was the first to use SPN-830 in the U.S., and results from the trial showed that the apomorphine infusion pump reduced ‘off’ time, when symptoms are not being adequately controlled, by an average of about three hours a day. This was reported by Stuart Isaacson, MD, a neurologist at the Parkinson’s…